Implantable Insulin Management for Type 1 Diabetics

by Gabrielle Taylor January 24, 2018

Implantable Insulin Management for Type 1 Diabetics

Type 1 Diabetes is one of Australia’s leading health problems, affecting over 120,000 people in our country alone. Patients with Type 1 Diabetes suffer as a result of their pancreas being unable to produce enough, or any, insulin. The immune system basically turns on itself and leaves sufferers requiring constant and regular injections to compensate.

However, recent research out of Cornell University, Novo Nordisk and University of Michigan Medical School, has contributed to the development of an implantable device that may be able to generate insulin much like a healthy pancreas.

According to an article on Medgadget, the device “harbors live stem cell-derived pancreatic cell clusters, known as islets...within a hydrogel and bind them to a polymer thread.”

The research was published in the Proceedings of the National Academy of Sciences (PNAS), and does warn that “the islets, not being a part of a proper organ, do have a lifetime after which they’re no longer useful. They can also lead to tumor formation, a real possibility.”

However, “being part of a thread allows them to be fairly easily removed and replaced as necessary,” at least according to the researchers.

The hydrogel coating on the islet cells effectively prevents the immune system from attacking them, and the ionised thread is structured in such a way so as to allow the living cells to adhere to it.

It is very new technology that has yet to be tested on humans, but it has shown promising results in the lab, able to obtain normal diabetic levels within only two days.

Although there is a seemingly a long road ahead, some respite for Type 1 Diabetics is closer than ever before.

You can read more about the study in PNAS, here: Designing a retrievable and scalable cell encapsulation device for potential treatment of type 1 diabetes…

 



Gabrielle Taylor
Gabrielle Taylor

Author




Also in Our Blog

IMPORTANT CHANGE IN THE SUPPLY OF SCHILLER AG PRODUCTS IN AUSTRALIA

by Mathew Packer June 12, 2018

Continue Reading

Artificial Intelligence for Cardiac Arrest calls
Artificial Intelligence for Cardiac Arrest calls

by Gabrielle Taylor January 18, 2018

At first, the two don’t seem like the most likely of partners, but Artificial Intelligence is currently being used to take emergency service calls in Denmark, helping to identify if Cardiac Arrest is present in the caller.

Continue Reading

Turn your health around in the new year
Turn your health around in the new year

by Gabrielle Taylor January 10, 2018

Finally, some good news: you can turn your health around, even once you’ve reached middle-age.

Continue Reading